An outbreak of a CTX-M-type beta-lactamase-producing Klebsiella pneumoniae: the importance of using cefpodoxime to detect extended-spectrum beta-lactamases.
Brenwald
Nigel P
NP
Jevons
Gail
G
Andrews
Jenny M
JM
Xiong
Jian-Hui
JH
Hawkey
Peter M
PM
Wise
Richard
R
D015296:Ceftizoxime / Q000031:analogs & derivatives* / Q000494:pharmacology*; D004196:Disease Outbreaks; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy* / Q000382:microbiology*; D007711:Klebsiella pneumoniae / Q000187:drug effects* / Q000201:enzymology / Q000302:isolation & purification; D008826:Microbial Sensitivity Tests / Q000706:statistics & numerical data; D008969:Molecular Sequence Data; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases / Q000096:biosynthesis* / Q000302:isolation & purification / Q000502:physiology*; D000097623:Cefpodoxime
D015296:Ceftizoxime; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases; D000097623:Cefpodoxime; C461660:beta-lactamase CTX-M-17, Klebsiella pneumoniae